1. Home
  2. SLBT vs KRNY Comparison

SLBT vs KRNY Comparison

Compare SLBT & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SL Science Holding Limited Ordinary Shares

SLBT

SL Science Holding Limited Ordinary Shares

N/A

Current Price

$0.54

Market Cap

644.9M

Sector

N/A

ML Signal

N/A

Logo Kearny Financial Corp

KRNY

Kearny Financial Corp

N/A

Current Price

$8.66

Market Cap

569.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SLBT
KRNY
Founded
N/A
1884
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Savings Institutions
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
644.9M
569.6M
IPO Year
2025
2014

Fundamental Metrics

Financial Performance
Metric
SLBT
KRNY
Price
$0.54
$8.66
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $10.50
AVG Volume (30 Days)
46.5K
★ 436.8K
Earning Date
10-26-2026
10-22-2026
Dividend Yield
N/A
★ 5.00%
EPS Growth
N/A
★ 35.71
EPS
N/A
★ 0.16
Revenue
N/A
★ $2,580,000.00
Revenue This Year
N/A
$10.19
Revenue Next Year
N/A
$12.02
P/E Ratio
★ N/A
$54.94
Revenue Growth
N/A
★ 36.00
52 Week Low
$0.57
$6.59
52 Week High
$6.25
$10.24

Technical Indicators

Market Signals
Indicator
SLBT
KRNY
Relative Strength Index (RSI) 22.09 31.67
Support Level N/A $8.29
Resistance Level $1.75 $9.63
Average True Range (ATR) 0.13 0.23
MACD -0.01 -0.05
Stochastic Oscillator 4.94 3.39

Price Performance

Historical Comparison
SLBT
KRNY

About SLBT SL Science Holding Limited Ordinary Shares

SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

About KRNY Kearny Financial Corp

Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income from their clients.

Share on Social Networks: